Incheon, South Korea

Ni Na Ha



Average Co-Inventor Count = 7.2

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2010-2012

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ni Na Ha: Innovator in Neuroprotective Pharmaceutical Compositions

Introduction

Ni Na Ha is a prominent inventor based in Incheon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in developing compositions that have neuroprotective effects. With a total of 2 patents, his work focuses on addressing degenerative brain diseases.

Latest Patents

Ni Na Ha's latest patents include a composition comprising oleic acid, which has been shown to possess neuroprotective activity. This invention relates to a pharmaceutical composition and health care food that utilizes oleic acid to prevent or treat degenerative brain diseases in humans and mammals. His second patent involves a pharmaceutical composition for protecting neurons, which includes an extract of Lithospermum erythrothizon or acetylshikonin as an effective ingredient. This composition is designed to prevent and treat ischemic neuronal diseases, demonstrating both safety and efficacy in protecting against conditions such as stroke and Alzheimer's disease.

Career Highlights

Throughout his career, Ni Na Ha has been associated with the University-industry Cooperation Group of Kyung Hee University and Neumed Inc. His work in these organizations has allowed him to advance his research and contribute to the development of innovative health solutions.

Collaborations

Ni Na Ha has collaborated with notable colleagues, including Hocheol Kim and Dae Hee Lee. These partnerships have played a crucial role in enhancing the impact of his research and inventions.

Conclusion

Ni Na Ha is a dedicated inventor whose work in neuroprotective pharmaceutical compositions has the potential to significantly improve the treatment of degenerative brain diseases. His innovative contributions continue to pave the way for advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…